Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • DNA/RNA Synthesis
    (6)
  • Telomerase
    (6)
  • Apoptosis
    (3)
  • Antiviral
    (1)
  • ERK
    (1)
  • Endogenous Metabolite
    (1)
  • Ferroptosis
    (1)
  • Histone Methyltransferase
    (1)
  • MEK
    (1)
  • Others
    (8)
Filter
Search Result
Results for "

telomere

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    14
    TargetMol | Inhibitors_Agonists
  • Compound Libraries
    1
    TargetMol | Compound_Libraries
  • Natural Products
    1
    TargetMol | Natural_Products
  • Recombinant Protein
    10
    TargetMol | Recombinant_Protein
  • Antibody Products
    7
    TargetMol | Antibody_Products
  • Cell Research
    1
    TargetMol | Disease_Modeling_Products
BCH001
T8647384859-58-9
BCH001 is a specific small-molecule inhibitor of PAPD5.
  • $43
In Stock
Size
QTY
FKB04
T200635
FKB04 is a telomeric repeat binding factor 2 (TRF2) inhibitor that exerts its antitumor activity by disrupting the telomere maintenance mechanisms in hepatocellular carcinoma cells. This leads to T-loop defects, inducing telomere shortening and cellular senescence. Additionally, FKB04 inhibits tumor growth in a human liver cancer xenograft mouse model (by implanting Huh-7 cells in BALB/c mice). This compound is utilized in research focused on liver cancer.
  • Inquiry Price
Inquiry
Size
QTY
TAC
TERT activator-1, TERT activator compound
T201368666699-46-3
TAC (TERT activator compound) is a TERT (telomerase reverse transcriptase) activator that enhances TERT transcriptional activity through the MEK/ERK/AP-1 cascade pathway, promotes telomere synthesis in primary human cells and naturally aged mice, reduces cellular senescence and inflammatory cytokines, and alleviates neuroinflammation, among other effects.
  • $30
In Stock
Size
QTY
TRF2-IN-1
T204175
TRF2-IN-1 (compound F2) is a potent inhibitor of telomere repeat-binding factor 2 (TRF2). It exhibits antiproliferative activity and induces apoptosis. TRF2-IN-1 binds directly to the TRF2TRFH domain, selectively inhibiting TRF2 protein expression and telomere localization. Additionally, TRF2-IN-1 possesses anticancer properties and shows potential for osteosarcoma research.
  • Inquiry Price
Inquiry
Size
QTY
TERT activator-2
T205533332939-29-4
TERT activator-2 (Compound 1030) is an activator of telomerase reverse transcriptase (TERT), which enhances the expression levels of TERT within cells. TERT activator-2 is applicable to research related to cellular lifespan and telomere functions.
  • Inquiry Price
10-14 weeks
Size
QTY
L2H2-6OTD intermediate-3
T208859
L2H2-6OTDintermediate-3 is an intermediate compound used in the synthesis of L2H2-6OTD, which is applicable in ADC preparation. L2H2-6OTD is a telomere inhibitor analogue with telomerase inhibitory activity (IC50: 15 nM).
  • Inquiry Price
Inquiry
Size
QTY
Telomeric G4s ligand 1
T2099043047091-81-3
Telomeric G4s ligand 1 is a telomere G-quadruplex ligand that stabilizes telomeric G4 structures and induces the formation of R-loops, leading to DNA damage responses. It prompts apoptosis in tumor cells and triggers immunogenic cell death (ICD).
  • Inquiry Price
10-14 weeks
Size
QTY
Anticancer agent 239
T210037
Anticanceragent 239 (Compound 5) is a ligand for the hTERT promoter G-quadruplex DNA structure (hTERT G4) with a dissociation constant (Kd) of 1.1 μM and reduces hTERT expression. It decreases telomerase activity, shortens telomere length, and induces DNA damage, acute cellular senescence, and apoptosis. Additionally, Anticanceragent 239 causes mitochondrial dysfunction, disrupts iron metabolism, and activates ferroptosis in cancer cells. It also inhibits tumor growth in MDA-MB-231 xenograft mouse models.
  • Inquiry Price
Inquiry
Size
QTY
Braco-19
T26892351351-75-2
Braco-19 is a telomerase/telomere inhibitor and an inhibitor of HAdV viral replication with antiviral activity that reduces lipid vacuolization in adipocytes, inhibits proliferation and decreases telomerase activity in human glioblastoma cells.
  • $48
In Stock
Size
QTY
Dot1L-IN-7
T629152580940-76-5
Dot1L-IN-7 (compound 25) is a selective and potent inhibitor of telomere silencing 1-like protein (DOT1L) with an IC50 of 1.0 μM. It selectively kills MLL-AF9 cells without affecting the growth of E2A-HLF cells.
  • $1,520
6-8 weeks
Size
QTY
ETP-47037
T630721316760-76-5
ETP-47037 is a potent inhibitor of the PI3Kα isoform (IC50: 0.99 nM) and inhibits the PI3Kβ (IC50: 49.2 nM), PI3Kδ (IC50: 7.13 nM) and PI3Kγ (IC50: 49.1 nM) isoforms. ETP-47037 has potential for telomere protection chemoregulation studies.
  • $1,520
10-14 weeks
Size
QTY
CRT0063465
T82667
CRT0063465 is a ligand for both human Phosphoglycerate Kinase 1 (PGK1) and the stress sensor protein DJ-1, exhibiting a dissociation constant (Kd) of 24 μM for PGK1. Additionally, it influences the composition of the shelterin complex and modulates telomere length [1].
  • Inquiry Price
Inquiry
Size
QTY
1-PP-myo-InsP5
TN11599149714-25-0
1-PP-myo-InsP5 is a type of inositol pyrophosphate. In mammals, it functions as a signaling molecule by interacting with specific receptors or through non-enzymatic phosphate transfer. Additionally, 1-PP-myo-InsP5 is involved in various biological processes, such as insulin signaling and the regulation of telomere length.
  • Inquiry Price
10-14 weeks
Size
QTY
PT-ttpy
TYD-01841727721-37-1
Pt-ttpy is a metallo-organic compound and an effective G-quadruplex ligand that efficiently induces significant telomere-associated DNA damage in cancer cells by inhibiting telomerase and/or telomere function. It also causes various chromatin abnormalities during mitosis, such as chromatin bridges, ultrafine bridges (UFB), and double-stranded breaks (DSB).
  • Inquiry Price
Inquiry
Size
QTY